COMPOSITIONS ET PROCEDES POUR L'ALTERATION DES PHENOTYPES XLHED

• 收藏
• 分享

专利权人:

INC.;EDIMER PHARMACEUTICALS

发明人:

SCHNEIDER, PASCAL,KOWALCZYK, CHRISTINE

申请号：

CA2835882

公开号：

CA2835882C

申请日:

2012.05.10

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The invention relates to methods for the temporal administration of EDA agonists, in particular EDI200, which correlate to optimal therapeutic response windows required for the formation of any EDA-dependent structures such as ectodermal appendages. Use of the methods described allow for the design of targeted therapeutic dosing and administration regimens in order to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/